Full-Time

Software Engineer II

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$85k - $130kAnnually

+ Incentive Compensation + Restricted Stock Units

Mid

Company Historically Provides H1B Sponsorship

Chicago, IL, USA

Hybrid role requiring some in-office presence.

Category
Full-Stack Engineering
Software Engineering
Required Skills
Agile
Python
React.js
MySQL
Node.js
Java
Postgres
GraphQL

You match the following Tempus's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • software development experience in both frontend and backend technologies
  • familiar with technologies such as: Node.js, React.js, Angular.js, Java, Python, MySQL, Postgres, REST, and GraphQL
  • worked in agile environments
  • comfortable iterating quickly
  • enjoy collaborating and communicating with team members of varying skill sets and from different fields
Responsibilities
  • set the goals
  • build the software
  • deploy the code
  • contribute to a growing software platform that will make a lasting impact in the field of cancer research and treatment
Desired Qualifications
  • Experience in Docker
  • Experience in AWS, GCP
  • Experience in Spark, Hadoop, Kafka, etc.
  • An interest in working in biotech, genomics, and precision medicine
  • Experience with technologies such as Kubernetes, BigQuery, or GCP’s Machine Learning infrastructure
  • worked in fast-paced, agile environments

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to assist physicians in making informed treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights, aiming to improve patient care and support drug development.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration in EHR systems supports Tempus' data analytics capabilities.
  • Growing demand for personalized medicine boosts Tempus' therapy solutions.
  • AI-powered health apps market growth supports Tempus' olivia app success.

What critics are saying

  • Ambry Genetics acquisition may strain Tempus' financial resources and integration efforts.
  • xT CDx test faces competition, impacting market penetration and revenue.
  • olivia app may raise privacy concerns, affecting user adoption and trust.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform offers personalized therapy options, enhancing patient care and drug development.
  • Tempus' pan-cancer organoid platform and liquid biopsy assay are unique in cancer research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus